Ophthalmic drug delivery system
First Claim
1. A drug delivery system comprising a contact lens having dispersed throughout as nanoparticles an ophthalmic drug nanoencapsulated with an encapsulation material, wherein said encapsulation material is selected dependent upon ophthalmic drug characteristics wherein a hydrophobic encapsulation material is selected for a hydrophobic ophthalmic drug and a hydrophilic encapsulation material is selected for a hydrophilic ophthalmic drug;
- wherein said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye;
wherein said diffusion results in extended or time-release delivery of said ophthalmic drug; and
wherein said nanoparticles are dispersed within said contact lens in an amount such that said contact lens remains optically transparent, wherein optically transparent is a degree of transparency equal to that of p-HEMA or other material employed as a contact lens.
1 Assignment
0 Petitions
Accused Products
Abstract
A drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 200 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye.
51 Citations
21 Claims
-
1. A drug delivery system comprising a contact lens having dispersed throughout as nanoparticles an ophthalmic drug nanoencapsulated with an encapsulation material, wherein said encapsulation material is selected dependent upon ophthalmic drug characteristics wherein a hydrophobic encapsulation material is selected for a hydrophobic ophthalmic drug and a hydrophilic encapsulation material is selected for a hydrophilic ophthalmic drug;
- wherein said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye;
wherein said diffusion results in extended or time-release delivery of said ophthalmic drug; and
wherein said nanoparticles are dispersed within said contact lens in an amount such that said contact lens remains optically transparent, wherein optically transparent is a degree of transparency equal to that of p-HEMA or other material employed as a contact lens. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
- wherein said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye;
Specification